Neuralstem Story

Neuralstem Inc -- USA Stock  

USD 1.79  0.03  1.70%

Macroaxis does not monitor all media channels or aggregates social signals for Neuralstem. But even though we do not provide professional-grade financial sentiment analysis on Neuralstem Inc, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Neuralstem. Check also Neuralstem Hype Analysis, Neuralstem Correlation and Neuralstem Performance
Taking a Fresh Look at Neuralstem, Inc.
In recent action, Neuralstem, Inc. has made a move of 79.46 percent over the past month, which has come on weak relative transaction volume. Reading the Tea Leaves for Neuralstem, Inc. - Economic News Broker Roundup on Neuralstem Inc - ExpertGazette

Read More...   

Story Momentum

This article from published on 07 of December contributed to the next trading period closing price depreciation.The overall trading delta to the next next day price was 10.71% . The trading delta at closing time when the story was published to current price is 20.98% .

Similar stores for Neuralstem

few days ago at 
Purchase by William Oldaker of 2500 shares of Neuralstem
Macroaxis News
Filed transaction by Neuralstem Inc director. General open market or private purchase of non-derivative or derivative security
over a month ago at 
Neuralstem to Participate at The Young Jewish Professionals CEO Healthcare ...
GlobeNewswire - Feb 8, 2018 GERMANTOWN, Md., Feb. 08, 2018 -- Neuralstem, Inc. , a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Richard Daly, Chairman and CEO of Neuralstem, will participate ...
over two months ago at 
Acquisition by Sandford Smith of 106952 shares of Neuralstem subject to Rule 16b-3
Macroaxis News
Filed transaction by Neuralstem Inc director. Grant, award or other acquisition pursuant to Rule 16b-3

Did you try this?

Run Efficient Frontier Now

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
Hide  View All  NextLaunch Efficient Frontier

Book Value Per Share

Book Value Per Share Comparative Analysis
  Book Value Per Share 
      Neuralstem Comparables 
Neuralstem is currently under evaluation in book value per share category among related companies. Book Value per Share (B/S) is can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing effects of liabilities. In other words a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of liquidation.